Aniling is a cutting-edge brand that is revolutionizing the field of epigenomics. Committed to bringing advancements in genomics to everyday healthcare and disease prevention, Aniling's technology solves critical limitations in DNA sequencing. By unifying genetic and epigenetic sequencing, their GEUS technology provides end-to-end solutions for precise treatment decisions in oncology.

Aniling offers a range of products based on their GEUS technology, which seamlessly integrate into the workflow from library preparation to clinical report. Their flagship product, GEUS-CLL, is a comprehensive Next Generation Sequencing diagnostics panel for Chronic Lymphocytic Leukemia. This groundbreaking product delivers accurate staging and treatment decisions for patients.

In addition to their product offerings, Aniling also provides the GEUS-CLL diagnostic test as a service to other laboratories and hospitals. Stay updated with the latest news from Aniling, including their recent participation in the CataloniaBio & HealthTech BBQ 2023 event. Connect with them and explore their blog to learn more about their innovative solutions for precision medicine and technology innovation.

Get in touch with Aniling today and be part of the future of epigenomics